Terumo Corp. (OTCMKTS:TRUMY) Short Interest Update

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 31,506 shares, a decline of 71.2% from the August 31st total of 109,382 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 135,496 shares, the days-to-cover ratio is currently 0.2 days.

Analyst Ratings Changes

Separately, Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy”.

Terumo Stock Performance

Shares of TRUMY stock opened at $14.59 on Friday. Terumo has a 12-month low of $12.08 and a 12-month high of $17.81. The firm has a market capitalization of $21.52 billion, a price-to-earnings ratio of 20.55 and a beta of 0.68. The business has a 50 day simple moving average of $15.05 and a 200 day simple moving average of $14.09. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.19 and a quick ratio of 1.37.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. The business had revenue of $1.97 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Terumo had a net margin of 13.83% and a return on equity of 10.44%. On average, equities research analysts anticipate that Terumo will post 0.7 EPS for the current year.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions.